XML 66 R51.htm IDEA: XBRL DOCUMENT
v3.25.1

Derivative financial instruments (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Text Block 1 [Abstract] |
Summary of Derivative Financial Instruments |
Purpose |  | Risk |  |  | Instrument |  | Notional |  |  | Settlement date |  |  | 12.31.2024 |  |  | 12.31.2023 |
Cash flow hedge designated as hedge accounting |  |  |  |  |  |  |  |  |  |  | (17.6 | ) |  |  | 8.9 |
Payroll expenses settled in Brazilian reais |  |  | Exchange rate |  |  | Zero-cost collar derivative financial instruments, with purchase of put options at the exercise price of R$5.00 and sale of call options at the weighted average exercise price of R$5.48 |  |  | — |  |  |  | 2024 |  |  |  | — |  |  |  | 8.9 |
|  |  |  |  |  | Zero-cost collar derivative financial instruments, with purchase of put options at the exercise price of R$5.42 and sale of call options at the weighted average exercise price of R$6.73 |  |  | 456.6 |  |  |  | 2025 |  |  |  | (17.6 | ) |  |  | — |
Others derivatives not designated as hedge accounting |  |  |  |  |  |  |  |  |  |  | (73.0 | ) |  |  | (116.6 | )
Export |  |  | Exchange rate |  |  | Non-Deliverable forwards to exchange euro currency debt to US dollar currency. |  |  | — |  |  |  | 2024 |  |  |  | — |  |  |  | (0.1 | )
Export |  |  | Exchange rate |  |  | Non-Deliverable forwards to exchange euro currency debt to US dollar currency. |  |  | 60.0 |  |  |  | 2025 |  |  |  | 2.5 |  |  |  | — |
Equity |  |  | Share price: ticker EMBR3 |  |  | Equity swap |  |  | — |  |  |  | 2024 |  |  |  | — |  |  |  | 8.5 |
Equity (i) |  |  | Share price: ticker EMBR3 |  |  | Equity swap |  |  | 53.9 |  |  |  | 2025 |  |  |  | 10.5 |  |  |  | — |
Equity (ii) |  |  | Share price: ticker EVEX |  |  | Private warrants |  |  | 14.2 |  |  |  | 2027 |  |  |  | (7.0 | ) |  |  | (14.0 | )
Equity (ii) |  |  | Share price: ticker EVEX |  |  | Public warrants |  |  | 8.2 |  |  |  | 2027 |  |  |  | (4.0 | ) |  |  | (11.3 | )
Equity (iii) |  |  | Share price: ticker EVEX |  |  | Strategic warrants |  |  | 32.5 |  |  |  | 2027 |  |  |  | (75.0 | ) |  |  | (99.7 | )
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (90.6 | ) |  |  | (107.7 | )
|  |  |  |  |  | Assets |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  |  |  |  |  | Current |  |  |  |  |  |  |  |  |  |  | 13.2 |  |  |  | 17.5 |
|  |  |  |  |  | Liabilities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  |  |  |  |  | Current |  |  |  |  |  |  |  |  |  |  | (71.9 | ) |  |  | (85.7 | )
|  |  |  |  |  | Non-current |  |  |  |  |  |  |  |  |  |  | (31.9 | ) |  |  | (39.5 | )
|  |  |  |  |  | Net derivative financial instruments |  |  |  |  |  |  |  |  |  |  | (90.6 | ) |  |  | (107.7 | )
(i) | In April 2024, the Company entered into 18-month swap contracts with Banco Santander S.A. Under these contracts, the Company will receive the price variation on 3,290,230 shares issued by Embraer (EMBR3) and will pay CDI plus 0.80% p.a. on the notional amount.
Additionally, in December 2024, the Company entered into 12-month swap contracts with Banco Itaú S.A. Under these contracts, the Company will receive the price variation on 4,032,300 shares issued by Embraer (EMBR3) and will pay CDI plus 0.70% p.a. on the notional amount. As of December 31, 2024, the Company had no margin calls related to these derivative financial instruments.
(ii) | Refers to the 8,203,407 (2023: 11,499,879) public warrants and 14,250,000 (2023: idem) private warrants issued by Eve Holding with a strike price of US$ 11.50 (eleven dollars and fifty cents) per share. The exercise period for these warrants will expire on the date that occurs first: May 9, 2027, the date set by the issuer to redeem all warrants or liquidation of the issuer.
The public warrants are listed and traded on the NYSE under the ticker EVEX.WS, and their fair value is derived directly from observable market prices. The fair value is calculated by multiplying the unit price of the option by the number of options. The private warrants have similar terms as the public warrants, except for the US$0.01 (one cent) cash redemption feature. The fair value measurement of the private warrants is identical to that of the public warrants since the differences between them do not affect their fair value.
(iii) | Refers to the 32,522,536 (2023: 37,422,536) strategic warrants units issued by Eve Holding under the following conditions:
| • |  | Penny warrants: 20,522,536 (2023: 20,422,536) units with an exercise price of US$0.01 (one cent) per share. The fair value measurement of this instrument considers the fair value of the EVEX share minus the exercise price. Furthermore, when the exercise of the option is conditioned on the occurrence of future events, the probability of these events occurring is also considered in the measurement.
| • |  | Market warrants: 12,000,000 (2023: 17,000,000) units with an exercise price of US$15.00 (fifteen dollars) per share. The Black-Scholes pricing model is used to measure the fair value of these financial instruments. In July 2024, 5,000,000 units with an exercise price of US$11.50 (eleven dollars and fifty cents) were extinguished as a result of the capital contribution made to Eve Holding. See further information in Note 2.3.1.
Summary of Other Comprehensive Income Related to Cash Flow Hedge | The amount reported in other comprehensive income related to cash flow hedge is detailed as follows:
|  | 12.31.2024 |  |  | 12.31.2023 |  |  | 12.31.2022 |
Changes in fair value |  |  |  |  |  |  |  |  |  |  |  |
Gain hedging reserve |  |  | — |  |  |  | 7.4 |  |  |  | — |
(Loss) gain cost of hedging reserve |  |  | (17.6 | ) |  |  | 1.6 |  |  |  | 2.3 |
Deferred tax |  |  | 6.0 |  |  |  | — |  |  |  | — |
Reclassification to profit or loss |  |  |  |  |  |  |  |  |  |  |  |
Fair value |  |  | (8.9 | ) |  |  | (2.5 | ) |  |  | 1.2 |
Other reclassifications |  |  | (4.2 | ) |  |  | 0.8 |  |  |  | 0.7 |
Total reported in other comprehensive income |  |  | (24.7 | ) |  |  | 7.3 |  |  |  | 4.2 |

X
- Definition Disclosure of detailed information about cash flow hedge movement in other comprehensive income explanatory. + References No definition available. + Details
Name: | erj_DisclosureOfDetailedInformationAboutCashFlowHedgeMovementInOtherComprehensiveIncomeExplanatory
Namespace Prefix: | erj_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of detailed information about derivative financial instruments. + References No definition available. + Details
Name: | erj_DisclosureOfDetailedInformationAboutDerivativeFinancialInstrumentsExplanatory
Namespace Prefix: | erj_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Text block 1. + References No definition available. + Details
Name: | erj_TextBlock1Abstract
Namespace Prefix: | erj_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration